Bristol-Myers Squibb Co at William Blair Biotech Focus Conference (Virtual) Transcript
Hi, everyone. My name is Matt Phipps, analyst here at William Blair. Thank you for joining us for this panel on the kind of cell therapies in the next decade. We just heard some exciting work being done at MSK on AML. And now we have a nice list of panelists here to kind of show what they're doing and talk about some of the key topics.
And so we'll start off with a quick introduction, a few slides for some of the people and then switch to the kind of more fireside discussion. And if you have any questions, please submit them in the chat, and we'll try to get them in. We have a lot to discuss, so let's get right into it.
We're going to kick it off with Rafael Amado, the EVP and CMO at Allogene Therapeutics. Rafael, go ahead and please start.
Yes. Thanks, Matt, and thanks for the invitation and from being
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
